Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Sawai to Make 700 Factory Contractors Permanent Employees
June 15, 2016
- SymBio Kicks Off Japan PIII for Patient-Controlled Pain Management Drug
June 15, 2016
- PDUFA Date Set for Jan. 31, 2017 for Daiichi Sankyo’s Nausea Drug
June 15, 2016
- Otsuka, Acucela End Partnership on AMD Drug after Trial Data Disappoint
June 15, 2016
- Ethical Drug Sales Up 8.1% in April: Crecon Report
June 14, 2016
- No Higher Mortality Risk Including CV Death Observed with Alogliptin against Placebo: Takeda
June 14, 2016
- Dave Fredrickson Tapped as Next Chief of AstraZeneca Japan
June 13, 2016
- Takeda Looks to Join Top 10 List in Global Oncology Space in 2025
June 10, 2016
- FY2015 Earnings Roundup - 5: 10 Firms Unveil Mid-Term Biz Plans, Many Play It Safe
June 10, 2016
- Mitsubishi Gas Chemical, Nippon Kayaku Form JV for Antibody, Biosimilar Production
June 10, 2016
- Takeda Gets Worldwide Rights to Theravance’s GI Drug Candidate
June 10, 2016
- Jacques Nathan to Lead Sanofi Japan from July 1
June 10, 2016
- AZ Japan Pres. Baertschi to Become CEO of Grünenthal in October
June 9, 2016
- Takeda, Ultragenyx Ink Strategic Partnership on Rare Genetic Diseases
June 9, 2016
- Shionogi to Transfer 3 Off-Patent Cancer Drugs to Nichi-Iko
June 9, 2016
- FY2015 Earnings Roundup - 4: Generic Biz Strategies Revolving around AG Launches
June 9, 2016
- Kaketsuken Announces Plan for Production Restart, Says Flu Vaccine Output Will Be Lower
June 9, 2016
- Kyowa Kirin, Medgenics Team Up on Severe Pediatric IBD Treatment
June 8, 2016
- FY2015 Earnings Roundup - 3: Japan Market Stagnates despite No Drug Price Revision, Off-Patent Brands Weigh
June 8, 2016
- Takeda, Roivant Form Joint Venture for Women’s Health, Prostate Cancer; Takeda Transfers 2 Investigational Products
June 8, 2016
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…